Biochemical challenges for testing novel anti-panic drugs in humans.

Autor: Abrams KB; Department of Psychology, Carleton College, United States of America. Electronic address: kabrams@carleton.edu., Folger IT; Department of Psychology, Carleton College, United States of America., Cullen NA; Department of Psychology, Carleton College, United States of America., Wichlinski LJ; Department of Psychology, Carleton College, United States of America.
Jazyk: angličtina
Zdroj: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2024 Sep; Vol. 242, pp. 173825. Date of Electronic Publication: 2024 Jul 14.
DOI: 10.1016/j.pbb.2024.173825
Abstrakt: Current medications for panic disorder each carry significant limitations that indicate the need for novel anxiolytics. The high costs and low success rates of drug development demand that testing trials be efficient. Lab panicogenic challenges in humans allow for the rapid biochemical induction of panic symptoms and hence an efficient means of testing potential anti-panic drugs. This paper describes ideal characteristics of lab panicogens, reviews the validity and utility of various biochemical panicogenic agents, identifies key outcome measures for studies of novel anti-panic drugs, and makes broad recommendations for labs wishing to perform such studies. We conclude by presenting a four-tiered hierarchy of panicogens that matches each against ideal characteristics and reflects our recommendations for their laboratory use.
Competing Interests: Declaration of competing interest The authors declare no conflicts of interest.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: